The Patent Finder

Inhibitors of Cysteine Proteases and Methods of Use Thereof (2021)

Pardes Biosciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 63/179,128, filed Apr 23, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,174,231Inhibitors of Cysteine Proteases and Methods of Use Thereof
In force
 · High confidence
Pardes Biosciences, Inc.In force
High confidence
US 11,524,940Inhibitors of Cysteine Proteases and Methods of Use Thereof
In force
 · High confidence
Pardes Biosciences, Inc.In force
High confidence
US 12,145,911Inhibitors of Cysteine Proteases and Methods of Use Thereof
In force
 · High confidence
Pardes Biosciences, Inc.In force
High confidence
Application 18/789,006Inhibitors of Cysteine Proteases and Methods of Use Thereofs
Pending
Not granted
Pardes Biosciences, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Pardes Biosciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited